doi: 10.1016/j.cytogfr.2022.09.003 24 ZhaoJZhenNZhouQLouJCuiWZhangGet al
The Critical Discovery When Raufman compared exendin-4's structure to other human peptides, he found that it matched GLP-1, a gut hormone that stimulates insulin production only when blood sugar is elevated
Insurance reviewers evaluate BMI (typically requiring 30 or 27 with comorbidities), previous weight loss intervention attempts, existing metabolic conditions, and provider rationale for GLP-1 selection
& Zak, A
Its meant to have low side effects, low costs, and help people ease into using the medication
Our story began with a shared vision: to leverage cutting-edge telehealth innovations to make safe, effective, and sustainable weight loss attainable for everyone